Sample Collection and Preservation: Establishing a Stable and Reliable Starting Point for Nucleic Acid Analysis

Across applications such as nucleic acid testing, metagenomics, and transcriptomics, sequencing platforms and bioinformatics pipelines are often not the dominant sources of error. Instead, data interpretability and reproducibility are primarily determined by the entire pre-analytical chain—from collection to preservation. The central engineering challenge for all nucleic-acid workflows is to maintain the in vivo molecular state as faithfully as possible once a specimen is removed from the body. Below is a structured overview of sample types, target molecules (DNA/RNA), preservation-system design, and representative use cases for sample collection and stabilization.

I. Sample Collection and Pre-Analytical Variables: “Upstream Control” of Nucleic Acid Quality

1.1 Amplification of pre-analytical errors

In nucleic acid testing, metagenomic profiling, and RNA-seq workflows, minor deviations introduced during the pre-analytical phase are frequently amplified nonlinearly during amplification, library construction, and downstream analysis. Typical outcomes include wasted sequencing depth, biologically meaningful differences being obscured by noise, and, in severe cases, incorrect biological conclusions.

Key pre-analytical variables that govern nucleic acid quality include:

(1) Collection timing and processing delay: prolonged room-temperature exposure accelerates RNA degradation, promotes DNA fragmentation, and can shift microbial composition;

(2) Temperature and repeated freeze–thaw cycles: low temperature suppresses metabolism and enzymatic activity, whereas frequent freeze–thaw accelerates nucleic acid breakage and induces lipid/protein denaturation;

(3) Chemical environment: pH, chelators, ionic strength, and preservatives collectively determine DNase/RNase activity and the rates of hydrolysis/oxidation;

(4) Collection media and containers: anticoagulant choice, RNase-free status, and compatibility with downstream extraction chemistries directly affect recovery efficiency and background interference.

1.2 Common mechanisms of degradation and bias

(1) Enzyme-mediated degradation: blood, tissues, and fecal samples contain abundant endogenous DNases/RNases and microbial nucleases; at room temperature, nucleic acid integrity can decline substantially within hours.

(2) Cell lysis and autolysis: osmotic shifts, mechanical shear, and thermal stress during collection and transport can rupture cells, releasing proteases and nucleases, accelerating degradation and reshaping molecular composition.

(3) Microbiome drift ex vivo: in fecal, oral, and respiratory specimens, environmental changes after collection drive differential microbial growth and death, resulting in “in vitro evolution” of the community structure away from the true in vivo state.

1.3 Sample type dictates preservation strategy

Sample types differ markedly in physicochemical properties, microbial burden, and the form of target nucleic acids:

Saliva/swabs: low host-cell content; host and microbial nucleic acids coexist; susceptible to environmental contamination and desiccation.

Feces: solid/semi-solid matrix; highly complex microbiota; rich in PCR inhibitors (bile salts, polyphenols, polysaccharides).

Blood: complex cellular components; high RNase burden; RNA is highly labile.

Tissues: metabolically active; sensitive to shear stress and osmotic changes; prone to autolysis and focal necrosis.

Purified plasmids or in vitro–transcribed RNA: typically high concentration but extremely sensitive to oxidation, freeze–thaw, and trace nuclease contamination.

Accordingly, a scientifically robust preservation system should be designed specifically for sample type and target molecule, rather than relying on a single “universal buffer” for all scenarios.

II. DNA-Primary Target: Collection and Preservation Strategies

2.1 Saliva/swabs: noninvasive sources of genomic DNA

Saliva and oral/pharyngeal swabs are widely used in cohort studies, genetic polymorphism analysis, forensics, and large-scale screening. Compared with blood sampling, they offer:

(1) noninvasive collection and operational simplicity, improving participant compliance and enabling non-clinical deployment;

(2) feasibility of mailing and remote sampling, supporting large cohorts and multicenter studies.

A DNA preservation system for these specimens typically needs to:

(1) rapidly lyse epithelial cells and expose genomic DNA while inhibiting nuclease activity;

(2) maintain long-term room-temperature stability (commonly 1–2 years), reducing reliance on cold-chain transport;

(3) suppress bacterial and fungal growth to reduce background signals and improve biosafety;

(4) remain highly compatible with common DNA extraction workflows (spin columns, magnetic beads) and downstream applications (SNP genotyping, arrays, NGS, qPCR).

2.2 Fecal samples: locking the original gut microbial community structure

Feces are central to microbiome profiling and fecal DNA analyses, but present multiple challenges:

(1) high microbial activity, with community structure drifting rapidly ex vivo;

(2) abundant inhibitors (bile acids, polysaccharides, polyphenols) that suppress PCR and library preparation;

(3) high matrix heterogeneity, with intrinsic sampling-position differences.

Typical design principles for fecal DNA preservation include:

(1) efficient chemical lysis to rapidly disrupt the matrix and release microbial DNA;

(2) simultaneous inhibition of DNases/RNases and proteases to maintain integrity;

(3) strong room-temperature stability for field sampling and ambient transport;

(4) maximal “freezing” of the community structure at the time of collection, minimizing abundance shifts driven by differential growth or death.

2.3 Plasmid DNA: long-term structural stability of engineered vectors and standard templates

For expression vectors, standard-curve templates, and positive controls, preservation aims extend beyond yield retention to maintenance of topology and functionality:

maintaining a stable supercoiled fraction to support transformation and expression;

avoiding fragmentation due to shear or chemical degradation;

minimizing conformational changes and activity loss driven by lyophilization and repeated freeze–thaw.

Plasmid preservation systems commonly adopt a “buffer + stabilizer + metal chelator” configuration:

(1) appropriate pH and ionic strength to maintain charge state and conformation;

(2) chelation of trace metal ions to suppress metal-dependent nucleases;

(3) compatibility with long-term storage at -20°C or 4°C and direct usability prior to transformation, transfection, or in vitro reactions.

III. RNA-Primary Target: Collection and Stabilization

3.1 Cells/tissues: “time-stamping” the transcriptome in situ

RNA is highly susceptible to RNases and environmental stress. Without rapid processing or freezing after collection, transcriptomic information can be irreversibly lost within a short time window. Traditional reliance on liquid nitrogen or dry-ice cold chains is costly and operationally error-prone in large-scale clinical sampling and field settings.

Core design principles for RNA preservation reagents include:

(1) rapid chemical penetration into cells to inactivate RNases and terminate transcription/translation and related cellular activities;

(2) maintenance of relative stability of mRNA and miRNA profiles at 4°C or room temperature over a defined window (days to weeks, depending on the system);

(3) direct compatibility as starting material for RNA extraction, minimizing high-risk steps such as centrifugation and transfers.

Such systems are applicable to blood cell pellets, cultured cells, tissue homogenates, and related specimen formats—particularly when immediate freezing is not feasible.

3.2 Blood RNA: approaching frozen preservation performance under ambient conditions

Peripheral blood transcriptomes reflect immune state and disease-associated expression patterns. However, whole blood contains abundant RNases, and blood cells remain transcriptionally active after collection. Improper handling can cause rapid and substantial expression-profile drift.

Blood RNA stabilization systems typically aim to:

(1) ensure immediate and thorough mixing post-collection, rapidly permeabilizing blood cells and inhibiting RNase activity;

(2) block signaling and transcription processes, “locking” the transcriptome at the time of collection;

(3) maintain RNA integrity and expression-profile stability within a defined window at room temperature or 4°C.

These systems are well suited to large cohorts, cross-site sample shipping, and field or primary-care phlebotomy settings, substantially reducing cold-chain dependence.

3.3 In vitro–transcribed RNA: high-fidelity preservation of standards and probes

In vitro–transcribed RNA is commonly used as:

templates for standard curves in quantitative assays;

templates for hybridization probes and in vitro translation;

spike-in controls and QC materials in sequencing workflows.

Despite high purity, such RNA lacks endogenous protective factors, creating key risks:

(1) trace RNase contamination (pipette tips, tube surfaces, airborne residues);

(2) freeze–thaw–driven strand breakage, aggregation, and conformational anomalies;

(3) chemical degradation via oxidation and base-catalyzed hydrolysis.

Preservation systems for in vitro–transcribed RNA generally should:

(1) ensure strict RNase-free performance and low trace-metal background to minimize enzymatic and chemical degradation;

(2) support storage at -20°C, -80°C, or liquid nitrogen, reducing physical damage at freezing interfaces;

(3) allow direct entry into reverse transcription or hybridization without requiring additional removal of stabilizers.

IV. Viral Specimens and Dual Protection of DNA/RNA

4.1 Fragility of viral nucleic acids and challenges of complex matrices

Viral nucleic acids in respiratory swabs, throat swabs, and other clinical specimens are often low copy and coexist with abundant host nucleic acids, proteins, and potential PCR inhibitors. Delays and temperature fluctuations between sampling and testing can markedly reduce viral detectability.

When only saline or conventional transport media are used, common problems include:

(1) rapid RNA degradation after virion disruption due to RNase activity;

(2)  repeated freeze–thaw causing envelope/capsid damage and nucleic acid shearing;

(3)  bacterial/fungal proliferation increasing enzymatic activity and metabolic byproducts, amplifying degradation and background interference.

4.2 Features of universal viral DNA/RNA preservation systems

Preservation systems designed for viral testing typically require:

(1) compatibility with both DNA and RNA viruses and with PCR/qPCR/RT-PCR and high-throughput sequencing;

(2) effective inhibition of nucleases and microbial growth at room temperature, supporting primary-care collection sites and ambient transport;

(3) high compatibility with column- or magnetic-bead–based extraction without precipitation, phase separation, or interference with lysis/binding/wash/elution steps.

Such systems are particularly important for infectious disease surveillance, emergency response, and large-scale screening, maintaining analytical validity where cold-chain capacity is limited.

V. Tissue and Integrated Sample Preservation Systems

5.1 Tissue preservation media: balancing morphology and molecular integrity

Solid tissues (tumors, organ samples, biopsy cores) are used both for routine pathology and for multi-omics analyses of DNA/RNA/protein. An ideal tissue preservation system should balance morphology and molecular preservation:

(1) maintain tissue architecture and cellular morphology under short-term 2–8°C storage, reducing autolysis, necrosis, and structural collapse;

(2) maximize nucleic acid and protein integrity and extractability during long-term storage at -20°C;

(3) remain compatible with tissue dissociation, primary culture, organoid establishment, and downstream nucleic acid extraction without materially suppressing enzymatic processes or library preparation efficiency.

In organoid workflows, pathology-adjacent molecular testing, and tissue multi-omics studies, appropriate tissue preservation media can substantially improve sample utilization and cross-project comparability.

5.2 Universal sample stabilizers: a “buffer layer” for heterogeneous sample workflows

In scenarios such as integrated sample collection, centralized temporary storage for prescreening, or cross-laboratory sample transfer, specimen types are heterogeneous and downstream analytical objectives may not yet be fully defined. In such cases, a universal stabilizing “buffer layer” can be particularly valuable by:

(1) suppressing degradation across a broad pH and matrix range, extending the usable time window;

(2) mitigating quality loss from freeze–thaw cycles, transport vibration, and short-term temperature fluctuations;

(3) providing time for secondary aliquoting and targeted downstream processing aligned to specific study objectives.

These stabilizers are well suited to collection/holding contexts where downstream pathways are undecided but overall quality must be protected—particularly for transit steps prior to external testing and for designs requiring multi-directional development of DNA/RNA/protein.

VI. System-Combination Logic in Representative Use Cases

6.1 Large-scale cohorts and biobank construction

To generate long-term, reusable high-quality nucleic acid resources in cohort studies and biobanks, a tiered preservation architecture can be built by specimen type:

(1) oral swabs/saliva: saliva/swab DNA preservation for ambient mailing and centralized processing;

(2) feces: fecal DNA preservative to lock gut community structure for 16S and metagenomics;

(3) whole blood: blood RNA stabilization to capture transcriptomes, combined with DNA extraction strategies for dual use;

(4) tissues: immediate placement into tissue preservation media, followed by project-specific branching to freezing, molecular extraction, or cell/organoid workflows.

6.2 Infectious disease surveillance and multi-source specimen integration

In pathogen surveillance and outbreak investigations, parallel handling of multiple specimen types is often required:

(1) throat/nasal swabs: universal viral DNA/RNA preservation to maintain pathogen nucleic acid stability and detectability;

(2) feces: nucleic acid detection and typing of bacterial pathogens/enteric viruses;

(3) blood: host immune response profiling, cytokines, and peripheral blood transcriptomics.

Using targeted preservation systems in combination can maximize retention of both pathogen information and host-response signals without materially increasing upstream workload, providing a high-quality specimen basis for host–pathogen interaction studies.

6.3 Standardized preservation of internal standards and QC materials

Routine laboratory operations rely on plasmid DNA, in vitro–transcribed RNA, and multi-level standards and spike-in controls:

(1) plasmid preservation systems enable long-term storage of expression vectors and positive controls, maintaining transformability and sequence integrity;

(2) in vitro–transcribed RNA preservation supports standard curve preparation and validation of sensitivity/linearity;

(3) universal stabilizers can serve as stable carriers for mixed QC samples, supporting batch preparation, aliquoting, and cross-lot use.

Aligning preservation strategies to critical molecular resources can materially improve methodological reproducibility and cross-batch/cross-platform data consistency.

VII. Aladdin-Related Products

Catalog No.	Product Name	Grade and Purity	Preservation Target	Downstream Applications
S774104	Saliva/Swab DNA Preservation Solution	BioReagent, ready-to-use, RNase free, sterile	DNA	DNA extraction; PCR/qPCR; sequencing pre-processing
R665499	RNAstore Sample Preservation Solution	BioReagent, ready-to-use, RNase free, sterile	RNA	RNA extraction; RT-qPCR; RNA-seq pre-processing
V751611	Universal Virus Sample DNA/RNA Preservation Solution	BioReagent, ready-to-use, sterile, RNase free	DNA/RNA	Nucleic acid extraction; PCR/RT-qPCR; sequencing pre-processing
P774108	Plasmid DNA Preservation Solution	BioReagent, ready-to-use, RNase free, sterile	Plasmid DNA	Plasmid storage and aliquoting; PCR/sequencing; (if needed) storage for transfection-grade plasmids
F774109	Fecal sample DNA preservation solution	BioReagent, ready-to-use, DNase, RNase, Protease free, sterile	DNA	DNA extraction; PCR/qPCR; metagenomics/sequencing pre-processing
I774110	In vitro transcriptional RNA preservation solution	BioReagent, ready-to-use, RNase free, sterile	In vitro–transcribed RNA	RNA storage and aliquoting; RT-qPCR; RNA-seq/functional assay pre-processing
R751648	UltraBio™ RNA Stabilization Reagent for Blood	BioReagent, ready-to-use, RNase free, sterile	Blood RNA	Blood RNA extraction; RT-qPCR; transcriptome sequencing pre-processing
S766791	Sample Protector for RNA	BioReagent, ready-to-use, Mycoplasma free, Suitable for molecular biology, RNase free, sterile, for DNA and RNA applications	RNA	RNA extraction; PCR/RT-qPCR; sequencing pre-processing
O1372282	Tissue Storage Solution	BioReagent, sterile-filtered, ready-to-use, for cell culture	Tissue (cell-culture related)	Tissue handling/transport for cell culture; downstream culture and experimental pre-processing

The essence of sample collection and preservation is to “freeze” the biological state at the time of collection as precisely as possible along the time axis, so that subsequent nucleic acid profiles remain as close as possible to the in vivo reality. Only by introducing preservation systems designed specifically for specimen type and target molecule properties at the moment of collection can pre-analytical bias be minimized in downstream testing and analysis.

Aladdin: https://www.aladdinsci.com/